Fig. 8From: Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi ArabiaTwo-dimensional plot showing the primary interacting residues of Cyclin D1Back to article page